cryptoingames| Cornerstone Pharmaceuticals and Ewpharma reach commercial strategic cooperation

News summary

[Cornerstone Pharmaceutical and Ewpharma reach a commercial strategic cooperation] Securities Times e Company NewscryptoingamesCornerstone Pharmaceuticals today announced that it has reached a strategic commercialization cooperation with European pharmaceutical company Ewpharma, granting Ewpharma the commercialization rights of suglimab in Central and Eastern Europe. According to license and vendorcryptoingames...

Newsletter text

[Cornerstone Pharmaceuticals and Ewpharma reach a commercial strategic cooperation] Securities Times e Company reported that Cornerstone Pharmaceuticals today announced that it has reached a commercial strategic cooperation with European pharmaceutical company Ewpharma, granting Ewpharma the commercialization rights of suglimab in Central and Eastern Europe. Under the licensing and commercialization agreement, Ewopharma will receive the rights to commercialize suglimab in Switzerland and 18 Central and Eastern European countries (CEEs).